جست‌وجوی استاد و پژوهشگر

• Chromosome Dynamics
• Epigenetics
• Genomic Instability
• +۳ مورد دیگر

Dr. Mathew J. Thayer is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern California, specializing in chromosome dynamics and epigenetic regulation. His research focuses on replication timing control, non-coding RNA interactions, and genomic stability mechanisms. California State University, Chico (BA: Microbiology & Chemistry, 1982) University of Southern California (PhD: Microbiology, 1988; Advisor: Dr. R.E.K. Fournier) Dr. Thayer's work has pioneered understanding of cis-acting elements that regulate DNA replication timing and chromosomal stability. He discovered ASAR lncRNA genes controlling replication patterns and identified chromosome-wide instability mechanisms linked to cancer. His recent publications demonstrate how heterogeneous nuclear ribonucleoproteins interact with ASAR RNAs to orchestrate replication timing, with implications for epigenetic inheritance and cancer genome evolution . Collaborations span cancer biology, developmental genetics, and chromatin research fields. Scientific recognition includes: John A. Resko Faculty Research Achievement and Mentoring Award (2017) Dr. Thayer has contributed to training students through publications and collaborative research, with ongoing work exploring RNA-based chromatin regulation and its role in disease states.

Chieko Mineoمشاهده پروفایل

استاد

• Cardiovascular Biology
• Metabolic Disorders
• Immunology
• +۳ مورد دیگر

Dr. Chieko Mineo is a Professor in the Department of Pediatrics and Department of Cell Biology at the University of Texas Southwestern Medical Center. She joined the faculty in 2002 after completing postdoctoral training there following her Ph.D. in Pharmacology from the University of Tokyo. Her research focuses on understanding endothelial cell functions in cardiovascular and metabolic diseases, including atherosclerosis, diabetes, and antiphospholipid syndrome. She is a Principal Investigator in the Shaul/Mineo Lab, collaborating with Dr. Phil Shaul, and leads the Center for Pulmonary and Vascular Biology. Education: B.S. and Ph.D. in Pharmacology from University of Tokyo; Postdoctoral training in Cell Biology at UT Southwestern Medical Center. Research Interests: Dr. Mineo studies endothelial cell signaling pathways, particularly the role of HDL receptors (e.g., SR-BI), estrogen receptor non-nuclear actions, and Fcγ receptor interactions in mediating vascular health. Her lab investigates how these pathways influence thrombosis, atherosclerosis, insulin resistance, and pregnancy-related complications. Recent work highlights mechanisms linking cholesterol metabolism, immune responses, and metabolic disorders. Publications: Over 50 peer-reviewed articles, with recent work focusing on novel therapeutic targets for antiphospholipid syndrome, HDL-mediated vascular protection, and estrogen's non-genomic effects. Key findings include identifying SR-BI's role in atherosclerosis and FcγRIIB's role in insulin resistance. Awards: Recognized for contributions to vascular biology and metabolic disease research Received grants from NIH and other funding bodies Grants/Advising: Active in securing NIH grants and mentoring students in vascular biology. Her lab supports collaborative research initiatives with the Center for Pulmonary and Vascular Biology. Labs/Teams: Co-directs the Shaul/Mineo Lab, integrating multidisciplinary approaches to study endothelial cell biology. The lab includes researchers focused on translational cardiovascular and metabolic medicine.

Archa Foxمشاهده پروفایل

استاد

• RNA biology
• paraspeckles
• long noncoding RNA
• +۷ مورد دیگر

Archa Fox is a Professor in the School of Human Sciences and the School of Molecular Sciences at the University of Western Australia, and an Honorary Research Fellow at the UWA Medical School and UWA Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research). She is also part of the Australian Centre for RNA Therapeutics in Cancer and serves as Chair of the RNA Network of Australia since 2015. Her research has significantly advanced the understanding of nuclear architecture and RNA biology. Professor Fox earned her Bachelor of Science at the University of New South Wales, majoring in molecular genetics, followed by her PhD at the University of Sydney (awarded in 2000). She completed postdoctoral research in Dundee, Scotland, where she integrated cell biology, microscopy, and molecular biology techniques. In 2006, she established her research group at the Western Australian Institute for Medical Research (now the Harry Perkins Institute), and in 2015, she transitioned to an academic position at the University of Western Australia. Her research centers on paraspeckles, nuclear bodies she discovered in 2002 that play crucial roles in gene expression regulation. Her work has revealed how paraspeckles malfunction in diseases like cancer. In 2009, she identified NEAT1 as the first long noncoding RNA that scaffolds a nuclear body, and in 2015, she demonstrated how intrinsically disordered protein regions contribute to paraspeckle formation. Her current research investigates paraspeckles as a model for understanding gene regulation through long noncoding RNAs and protein aggregation, with collaborations across multiple scientific disciplines. Analysis of Professor Fox's recent publications (2022-2025) reveals a strong focus on nuclear architecture, RNA-binding proteins, and the molecular mechanisms of paraspeckle formation and function. Her work spans structural biology, cancer research, and the emerging field of biomolecular condensates, with particular emphasis on DBHS family proteins (SFPQ, NONO, PSPC1) and their roles in phase separation and nuclear organization. Scientific Awards: Marshall Medal of the Harry Perkins Institute (2012) Emerging Leader Award of the Australian/NZ Society for Cell and Developmental Biology (2017) School of Human Sciences Senior Research Award (2023) Vice Chancellor's Senior Research Award (2023) UWA Student Guild's Students' Choice Awards (2018) Professor Fox has been actively involved in mentoring and research leadership, with 8 supervised works documented. She has secured significant research funding, including 48 grants such as the 'STUNNER for RNA encapsulation quality and deliver' project funded by The Ian Potter Foundation (2024-2025) and the 'WA RNA Salon' project funded by The RNA Society (2024-2025). Her collaborative approach is evident in multi-investigator projects like the 'Broadening assay capabilities with CLARIOstar Plus multimode platereader' (2025-2035). Her laboratory forms part of the Australian Centre for RNA Therapeutics in Cancer and maintains strong affiliations with the Harry Perkins Institute of Medical Research. Professor Fox has also been instrumental in community engagement, participating in the Wembley Primary School Community STEAM program and Pint of Science presentations, demonstrating her commitment to science communication and public outreach.

• Aged care nursing
• Geriatrics and gerontology
• Acute care

Helga Jenkins is a Lecturer in Dementia Studies at the Wicking Dementia Research Education Centre, University of Tasmania. Her research focuses on aged care nursing, geriatrics, and acute care. She holds an ORCID identifier (0000-0003-3146-7159) and can be reached at Helga.Merl@utas.edu.au . Her research interests include improving dementia care practices through education, interdisciplinary models, and ethical considerations. She has contributed to studies on rural healthcare access, integrated care outcomes, and innovative dementia diagnosis approaches. Funded Projects: "Laughter ISLAND: Using comedy to promote brain health" (2022-2024, $5,000 grant) "Guide for medical practitioners in Tasmanian minority communities" (2022-2025, $5,000 grant) Jenkins collaborates actively with academic networks via LinkedIn and ResearchGate, advancing dementia education and clinical practice. Her work emphasizes practical interventions to reduce health disparities and enhance care quality for aging populations.

• Therapeutic Angiogenesis
• Vascular Biology
• Cardiovascular Disease
• +۳ مورد دیگر

Ayman Al Haj Zen is a Visiting Scientist and Research Fellow at the University of Oxford , based in the Division of Cardiovascular Medicine and the Target Discovery Institute (TDI) . He holds an MD and PhD from the University of Paris VII (2006), specializing in vascular repair and atherosclerosis. Prior to Oxford, he conducted postdoctoral research at the London Research Institute and the University of Bristol , focusing on vascular development and ischemia-induced angiogenesis. His research emphasizes therapeutic angiogenesis , targeting chronic vascular diseases like peripheral arterial disease and non-healing wounds. He employs in vitro angiogenesis assays , high-throughput screening, and quantitative imaging to identify novel therapeutic strategies. Notable findings include the discovery of Tazarotene’s role in wound regeneration and Lacidipine’s effects on vascular lumen expansion. His work also explores paracrine signaling interactions between microvascular networks and diseased microenvironments using 2D/3D co-culture models and murine models of angiogenesis. This approach aims to identify translational targets for chronic vascular therapies. Awards: Intermediate Research Fellowship from the British Heart Foundation (Oxford Centre of Research Excellence, 2013) Labs/Teams: Collaborates with the Watkins Group (Inherited Heart Muscle Disease) and the Oxygen Sensing Lab (Peter Ratcliffe group) . His research integrates molecular signaling, regenerative medicine, and translational drug discovery.

• Infectious diseases
• Maternal and Child Health
• Pediatrics
• +۳ مورد دیگر

Nicole E Smolinski is a Research Assistant Professor in the Department of Pharmaceutical Outcomes & Policy at the University of Florida. She holds a Pharm.D. from Midwestern University (2019) and a Ph.D. from the University of Florida (2024). Her research focuses on maternal and child health, particularly pediatric acute otitis media and medication safety during pregnancy. She collaborates with Dr. Almut Winterstein and has expertise in drug utilization patterns, teratogenic risk mitigation, and algorithm development for health data analysis. Education: - B.S. Child Psychology & B.A. Chemistry (2015), University of Minnesota - Pharm.D. (2019), Midwestern University - Ph.D. in Pharmaceutical Outcomes & Policy (2024), University of Florida Research Interests: - Infectious diseases in children - Medication safety during pregnancy - Development of decision support tools for teratogenic risk mitigation - Population-based studies on drug exposures and fetal/neonatal outcomes Recent Work Trends: Her publications emphasize algorithmic approaches to analyze healthcare claims data, particularly for predicting stillbirths and identifying teratogenic medication exposures. She has contributed to studies on biologic use in autoimmune conditions during pregnancy and NSAID prescribing trends in ambulatory care. Awards: - DuBow Graduate Student Fellowship (2019, University of Florida) Grants & Collaborations: - Active projects include the TRIM tool development for prioritizing medication risk mitigation - Co-investigator on studies involving medical cannabis use in Florida Labs & Teams: Affiliated with the University of Florida’s Pharmaceutical Outcomes & Policy department, specializing in maternal and child health outcomes research.

Rodney Infanteمشاهده پروفایل

دانشیار

• Cancer Cachexia
• Adipose Tissue Biology
• Cholesterol Transport
• +۴ مورد دیگر

Rodney Infante, M.D., Ph.D., is an Associate Professor at UT Southwestern Medical Center, holding primary appointment in the Center for Human Nutrition and secondary appointments in the Department of Molecular Genetics and Department of Internal Medicine (Division of Digestive & Liver Diseases). He specializes in general gastroenterology and cancer cachexia. His research focuses on molecules and mechanisms driving adipose wasting in cachexia, particularly in oncologic, liver, and infectious diseases, with aims to identify therapies for cachexia and insights into obesity treatment. Education: B.S. in Accounting (University of Florida), M.D./Ph.D. (UT Southwestern), residency at Massachusetts General Hospital, gastroenterology/human nutrition fellowships at UT Southwestern. Awards: 2019 Burroughs Wellcome Career Award for Medical Scientists, 2019 AGA Research Scholar Award. Key research interests include cytokine-mediated adipose loss (e.g., leukemia inhibitory factor [LIF]), JAK inhibitor therapies, and cholesterol trafficking. He collaborates with oncologist Puneeth Iyengar on cachexia databases linking clinical observations to preclinical studies. His lab investigates cachexia mechanisms in gastrointestinal and lung cancers, leading to a phase 1 trial of JAK inhibitors. Publications highlight cachexia pathogenesis, JAK/STAT signaling pathways, and metabolic disease intersections. He is affiliated with the Harold C. Simmons Comprehensive Cancer Center and leads the Infante Laboratory at UT Southwestern.

Yi-Ting Tzenمشاهده پروفایل

پژوهشگر

• Pressure Injury Prevention
• Spinal Cord Injury Rehabilitation
• Biomarkers in Wound Care
• +۳ مورد دیگر

Dr. Yi-Ting Tzen is a Principal Investigator at the UT Southwestern Medical Center's School of Health Professions, Department of Physical Medicine and Rehabilitation. Her research focuses on early detection and prevention of pressure injuries in individuals with spinal cord injury (SCI), leveraging biomarkers, non-invasive perfusion monitoring, and assistive technologies. She has clinical expertise in physical therapy and bioinstrumentation, with a strong background in signal processing and rehabilitation engineering. Key research areas include identifying risk factors for pressure injuries, evaluating interventions like local cooling and alternating pressure devices, and exploring lipidomics and serum biomarkers for early prediction. Collaborations include work with orthopedic surgery and PM&R departments at UT Southwestern. Recent contributions include presentations at the 2024 ACRM Conference and NPIAP Webinar, and leadership roles in the National Pressure Injury Advisory Panel. She has secured grants from the Paralyzed Veterans of America and received the 2023 UT Southwestern Research Recognition Award. Her lab, the Tzen Lab, mentors students in lipidomics, wound care, and musculoskeletal imaging, with alumni advancing to academic and clinical roles in rehabilitation medicine.

• Financial Econometrics
• Market Microstructure
• Nonlinear Filtering
• +۷ مورد دیگر

Giuseppe Buccheri serves as an Associate Professor of Econometrics (13/ECON-05) in the Department of Economics at the University of Verona since 2024. Previously, he held positions as senior assistant professor (RTDB) at the same department and junior assistant professor (RTDA) at the Department of Economics and Finance of University of Rome Tor Vergata. His academic appointments include membership on the Faculty Board of PhD in Economics and Finance, Collegio didattico di Economics and Data Analysis, Research Commission, and Economics Department Council. His educational background features a PhD in Financial Mathematics from Scuola Normale Superiore, an MSc in Finance from Bocconi University, and an MSc in Theoretical Physics from the University of Catania. This interdisciplinary foundation supports his research at the intersection of financial theory, statistical methods, and economic applications. Dr. Buccheri's research focuses on advanced econometric techniques for financial markets, particularly in Financial Econometrics, Market Microstructure, Nonlinear Filtering, and Financial Economics. His work addresses critical challenges in time-series analysis, model validation, volatility estimation, and portfolio optimization. The JEL classifications of his research span C32 (Time-Series Models), C52 (Model Evaluation), C58 (Financial Econometrics), and G11 (Portfolio Choice). His recent publications demonstrate a strong trend toward developing sophisticated statistical methods for high-frequency financial data analysis, with particular emphasis on score-driven models, realized volatility/covariance estimation, and handling market microstructure effects. These contributions advance the field by addressing measurement errors, asynchronous trading, illiquidity effects, and model identification challenges in modern financial markets. As an educator, Dr. Buccheri teaches Financial Econometrics, Quantitative Methods for Business and Economics, and Time Series and Forecasting across multiple graduate programs including Master's degrees in Banking and Finance and Economics and Data Analysis, as well as PhD courses in Financial Time Series. He serves on various academic committees related to research, teaching, and PhD program governance. His research activities connect with several institutional resources including CIDE (Centro Interuniversitario di Econometria) and the broader econometric research community at the University of Verona. His work contributes significantly to the department's research profile in quantitative methods for economics and finance.

Mauro Perrettiمشاهده پروفایل

استاد

• Immunopharmacology
• Inflammation Resolution
• Annexin A1 System
• +۴ مورد دیگر

Professor Mauro Perretti serves as Professor of Immunopharmacology and Deputy Director at The William Harvey Research Institute, Queen Mary University of London, within Barts and The London School of Medicine and Dentistry. He has held his professorial chair since September 2001 and has been Deputy Director of the Institute since September 2006. His academic journey includes previous positions as Reader in Immunopharmacology and Senior Lecturer at the same institution. Professor Perretti's research focuses on the investigation of endogenous mediators that actively promote resolution of inflammation for the regain of tissue homeostasis. His laboratory, comprising over 15 scientists, students, and visiting fellows, studies specific elements of the endogenous inflammatory response with a dual approach: determining the patho-physiological relevance of mediators in acute and chronic inflammation models, and identifying targets for innovative drug discovery. His work spans multiple systems including the Annexin A1 system, melanocortin peptide system, galectins, and glucocorticoids. Analysis of his publication record reveals a consistent focus on inflammation resolution mechanisms, particularly the role of endogenous anti-inflammatory mediators. His research shows a progression from basic mechanisms of leukocyte migration to translational applications, with increasing emphasis on therapeutic development in recent years. His work bridges fundamental immunology with pharmacological applications, particularly in arthritis and other inflammatory conditions. Cattlin Prize (1998) - awarded as an 'Excellent Non-Clinical Scientist' Quintiles Prize (2000) - for 'Outstanding research in immunopharmacology' Fellow of the British Pharmacological Society (2004) Fellow of the Academia Europea (2010) Personal Chair at Queen Mary University of London (2001) Professor Perretti has served on numerous editorial boards including the British Journal of Pharmacology and as Principal Editor of The Scientific World. His laboratory has secured significant research funding, including fellowships from the Arthritis Research Campaign, and has established commercial partnerships with Unigene Corp, Action Pharma A/S, and UCB. His work on the Annexin A1 system has resulted in two licensed patents. The MP laboratory employs a multinational team utilizing advanced techniques including intravital microscopy, genetically modified animals, and flow chamber assays to study leukocyte trafficking in various disease models ranging from arthritis to cystic fibrosis.

Richard M. Higashiمشاهده پروفایل

استاد

• Cancer Biology
• Metabolic Pathways
• Oncology
• +۵ مورد دیگر

Richard M. Higashi, PhD, is a Professor in the Department of Toxicology and Cancer Biology at the University of Kentucky. He holds affiliations with the Center for Environmental and Systems Biochemistry, focusing on metabolic pathways in cancer. His research emphasizes stable isotope-resolved metabolomics (SIRM) to study tumor metabolism, drug responses, and the tumor microenvironment. Key areas include metabolic reprogramming in breast and lung cancers, immune cell metabolism, and developing preclinical models for personalized medicine. Research interests span cancer metabolism, immunometabolism, and novel therapeutic strategies targeting metabolic vulnerabilities. Notable contributions include organoid-based platforms for patient-specific analyses and identifying metabolic biomarkers for treatment efficacy. His work integrates advanced mass spectrometry and metabolomics techniques to dissect cell-type specific metabolic profiles in tumors and immune cells. Publications highlight metabolic heterogeneity in NSCLC, mitochondrial dysfunction in radiation resistance, and CD8+ T cell metabolic adaptations enhancing antitumor activity. His team explores selenium-based therapies and exosomal biomarkers for cancer diagnosis. Collaborations focus on translating metabolomics data into clinical applications for precision oncology. Advising and grants are not explicitly detailed in the provided text, but his lab likely engages in multidisciplinary projects at the interface of basic metabolism and clinical oncology. The Center for Environmental and Systems Biochemistry supports systems-level approaches to environmental toxin impacts and cancer biology.

Zhao Yangمشاهده پروفایل

پژوهشگر ارشد

• Molecular Biology
• Genetics
• Toxicology
• +۳ مورد دیگر

Zhao Yang is a postdoctoral research fellow at Wayne State University's Petriello Lab. He holds a Master's degree (2014) and PhD (2019) in Pharmaceutical Sciences and Molecular Biology and Genetics, respectively, from Wayne State University. Education M.S. in Pharmaceutical Sciences (Wayne State University, 2014) Ph.D. in Molecular Biology and Genetics (Wayne State University, 2019) Zhao Yang's research focuses on molecular mechanisms of transcription factors in hepatic diseases and cardiometabolic effects of persistent organic pollutants such as PCB 126 and PFAS. His work explores how environmental toxins modulate metabolic pathways, including cholesterol metabolism and oxidative stress, and investigates proteomic interactions of detoxification enzymes like FMO3. Additional studies examine stress-sensing transcription factors (CREBH, ATF6) and their regulatory roles in autophagy and hepatic steatosis. Recent publications highlight his expertise in environmental toxicology and metabolic disorder research . Key findings include PCB 126-induced endothelial dysfunction via 4-Hydroxy-2 Nonenal, PFAS effects on sex-dependent cholesterol metabolism, and CREBH's role in stress-induced hepatic steatosis. His proteomics work identifies FMO3 interaction partners linked to urea cycle regulation. Zhao Yang's collaborations span Wayne State University's environmental health initiatives, with co-authorships on reviews about urban volatile organic compound contamination in Detroit. His research integrates molecular biology, environmental exposure, and metabolic health outcomes.

Xiaoqing Tangمشاهده پروفایل

استاد

• Diabetes Research
• MicroRNA Biology
• Pancreatic Beta-Cell Function
• +۴ مورد دیگر

Dr. Xiaoqing Tang is a Professor in the Department of Biological Sciences at Michigan Technological University (MTU) and serves as the Graduate Program Director for the Biological Sciences program. He holds a PhD from the Weizmann Institute of Science (Israel, 2003). His research focuses on the role of microRNAs (miRNAs) in pancreatic beta-cell function and diabetes pathogenesis, with a particular emphasis on miRNA regulation of insulin production/secretion and diabetes biomarker discovery. He has pioneered high-throughput miRNA array technologies and developed novel miRNA-based therapies for diabetes. Dr. Tang's lab investigates miRNA-mediated control of beta-cell identity, glucose responsiveness, and diabetic complications. Key areas include miRNA's role in beta-cell dedifferentiation, ALDH1A3 targeting, and MAP4K4 regulation. His work integrates molecular biology, bioengineering (e.g., composite bioadhesives), and systems biology approaches. He teaches advanced courses in genomics, molecular diagnostics, and biochemistry laboratory techniques. Notable contributions include identifying miR-30d and miR-483 as critical regulators of beta-cell function, discovering blueberry's protective effects on beta-cells in obesity models, and developing STTM (short tandem target mimic) technology for miRNA inhibition. Current efforts focus on translating miRNA discoveries into diagnostic tools and therapeutic strategies for diabetes. Dr. Tang actively mentors graduate students through MTU's Accelerated MS Program and collaborates on projects involving miRNA profiling in diabetic mouse models. His research has been published in journals like Non-Coding RNA , Biophysical Journal , and Endocrinology , with over 60 peer-reviewed articles to date.

Matthias Kupplerمشاهده پروفایل

پژوهشگر

• Cultural Sociology
• Analytical Sociology
• Social Network Analysis
• +۷ مورد دیگر

Matthias Kuppler is a Researcher at the University of Siegen, affiliated with the Sociology department in Faculty I (Social Sciences). He holds a B.Sc. in Social Sciences and an M.Sc. in Sociology and Social Research from the University of Cologne. His research focuses on analytical sociology, social network analysis, and agent-based modeling to explore cultural exchange dynamics and artistic communities. Central to his work is the EUROLIT project, analyzing literary translation networks across Europe to identify underlying social mechanisms. He previously collaborated on family sociology and social gerontology with Prof. Michael Wagner, and explored algorithmic fairness with Dr. Christoph Kern. His contributions span interdisciplinary methods, addressing topics like global literary fields, automated decision-making ethics, and aging-related policies. Education: B.Sc. Social Sciences, University of Cologne (2013–2017) M.Sc. Sociology and Social Research, University of Cologne (2017–2019) Professional Experience: Research Associate, University of Siegen (2022–present) Fellow, Graduate School of Economic and Social Science, University of Mannheim (2020–2021) Research Associate, University of Cologne (2019–2020) Research Projects: EUROLIT: Analyzing European literary translation networks (2022–2024) Family sociology and aging studies under Prof. Wagner Algorithmic fairness in machine learning Research Themes: Kuppler’s work bridges macro-level cultural phenomena and micro-level social interactions. His EUROLIT project addresses intercultural exchanges through network analysis, while his earlier studies explored longitudinal family dynamics and methodological challenges in surveying elderly populations. He critically examines fairness in AI systems, linking technical metrics to sociopolitical implications. Grants & Collaborations: Involved in DFG-funded projects, notably the EUROLIT initiative. Collaborates with institutions like the University of Mannheim on interdisciplinary topics. His work appears in venues such as the DFG Gepris platform and international conferences. Labs & Teams: Contributing to the EUROLIT team at the University of Siegen, focusing on large-scale translation data collection and modeling. Engaged in collaborative networks across European universities for cultural sociology research.

Sotirios Kokasمشاهده پروفایل

استاد

• Financial Networks
• Syndicated Loan Market
• Financial Regulation
• +۵ مورد دیگر

Professor Sotirios Kokas is a faculty member at the University of Essex's Essex Business School, where he holds the rank of Professor in Finance. He is a Fellow of the Higher Education Academy and maintains active research collaborations with institutions like the Bank of Finland and BIS. His research focuses on empirical banking, with emphasis on: Financial networks and systemic risk propagation Impact of monetary policy on banking stability Syndicated loan market dynamics Bank competition and foreign ownership effects Regulatory frameworks in credit markets His recent publications (2021-2025) demonstrate strong focus on banking resilience during economic shocks, credit market efficiency, and diversity in finance. Key themes include liquidity risk management during crises, gender diversity impacts on lending, and central bank independence. Awards: Fellow of the Higher Education Academy He currently supervises three PhD students researching ESG performance, government subsidies, and economics. His funded project (2024) with PricewaterhouseCoopers examines 'Modelling Greek Firms’ Survival Rates and Identifying "Zombies"'.